Search
PSM is still monitoring public reports of dangerous counterfeit medical supplies and treatments. Here’s a quick round-up of counterfeit news published the week May 18, 2020.
Read MoreMaine submitted a state importation plan to the U.S. Department of Health and Human Services (HHS) recently to meet its own May 1, 2020 deadline. Given the deep structural flaws in both the idea of importing medicine from Canada and in Maine’s application to do so, PSM wonders if there is a better use of Maine taxpayer dollars than to continue to pursue this idea.
Read MoreOur #covidscams bookmark educates patients about five kinds of online crime that have spiked since the pandemic. Download a copy for yourself and visit our covid-19 scams tracking page to catch up on the news.
Read MorePSM is still monitoring public reports of dangerous counterfeit medical supplies and treatments. Here’s a quick round-up of counterfeit news published the week May 11, 2020.
Read MoreLast week PSM asked Congress to help protect the public from online COVID-19 scams by requiring domain name sellers to suspend and lock websites that facilitate health fraud and re-opening registration information so that law enforcement can pursue criminals using websites to take advantage of the public.
Read MoreAs we’ve focused these last few weeks on COVID-19 scams related to medicine and medical supplies, however, another population of scammers has been exploiting Americans. This week we’re calling out financially-focused covidscams, which comprise a large part of the $13.4 million that U.S. citizens have lost to fraud since the beginning of the year.
Read MoreThe following policy resolution was passed unanimously at the May 8, 2020 Advisory Board meeting: The Partnership for Safe Medicines believes that counterfeit medical devices are dangerous to American patients and that the U.S. Food and Drug Administration (FDA) should have the unequivocal power to seize and destroy these dangerous products whether they are found in interstate commerce or in…
Read MoreThis is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. May 11, 2020 Company Contact Information Consumers: Lin Leung, MasterPharm, LLC Phone: (866) 630-5600 Email: recall@masterpharm.com Company Announcement MasterPharm, LLC. is…
Read MorePSM is still monitoring public reports of dangerous counterfeit medical supplies and treatments. Here’s a quick round-up of counterfeit news published the week May 4, 2020.
Read MoreLaw enforcement is encountering problems kicking COVID-19 scammers offline. Learn how, and how we can fix it.
Read More